BCI can assist
in the development and/or review of labeling and promotional materials
that are appropriately fair balanced and compliant with relevant
regulatory guidelines. BCI’s consultants will help to ensure
that labeling and promotional materials are scientifically accurate,
clinically relevant, and in compliance with the guidelines of relevant
Office of the Inspector General (OIG), FDA, Pharmaceutical Research
Manufacturers Association (PhRMA), International Federation of Pharmaceutical
Manufacturers Association (IFPMA), EMEA, PMDA, DCGI (India), Health
Canada, TGA (Australia) and other countries.
|